Beranda › Penyakit Paru › Alabama
Uji klinis Penyakit Paru di Alabama
13 studi untuk Penyakit Paru mencari peserta di lokasi di Alabama.
Kota di Alabama
Teks studi resmi (Bahasa Inggris)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Birmingham
- Research Site, Mobile
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05624450A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- University of Alabama at Birmingham, Huntsville Regional Medical Campus (HRMC), Huntsville
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06679140Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
- Clearview Cancer Institute (Crestwood), Huntsville
- Clearview Cancer Institute, Huntsville
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07489066A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- University of Alabama at Birmingham, Birmingham
Menerima pesertaFase 2
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07759245American Lung Association (ALA) Lung Health Cohort
- University Of Alabama, Birmingham
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 25 hingga 35 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT04543461A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Velocity Clinical Research, Mobile, Mobile
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06977581A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Clearview Cancer Institute, Huntsville
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06119581Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Alabama, Birmingham
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07059091A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 106, Birmingham
Menerima pesertaFase 3
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT07555483Deep Functional Phenotyping of the ALA Lung Health Cohort
- University of Alabama, Birmingham
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 25 hingga 35 · Semua jenis kelamin · Diperbarui 17 Jul 2026 · NCT06177717Housing, Environment, And Living Conditions for Transformed Health
- UAB Lung Health Center, Birmingham
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 89 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT06925373Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- University of Alabama at Birmingham, Birmingham
- University of South Alabama, Mobile
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Apr 2026 · NCT05297734Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- University of Alabama at Birmingham, Birmingham
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 12 Nov 2025 · NCT05975983Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.